BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12908778)

  • 1. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
    Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
    Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
    Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
    Pan Z; Fu Z; Luo C; Bao Y; Wang M; Cao W; Xu X
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2145-2151. PubMed ID: 34537906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
    Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
    Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
    Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
    Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): analysis in Italian patients.
    Ruzzo A; Graziano F; Costagliola A; Arduini F; Testa E; Bearzi I; Cortese G; De Gaetano A; Andreoni F; Lai V; Magnani M
    Tumour Biol; 2003; 24(3):147-50. PubMed ID: 14610318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family.
    Zhu ZG; Yu YY; Zhang Y; Ji J; Zhang J; Liu BY; Chen XH; Lu Y; Jiang HS; Bu L; Hu LD; Kong XY
    Eur J Surg Oncol; 2004 Jun; 30(5):531-5. PubMed ID: 15135482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
    Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
    J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.